Literature DB >> 20458266

Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.

Yue Wang1, Aaron M Abarbanell, Jeremy L Herrmann, Brent R Weil, Jeffrey Poynter, Mariuxi C Manukyan, Paul R Crisostomo, Daniel R Meldrum.   

Abstract

Toll-like receptors (TLRs) play a key role in innate immune defenses. After activation by foreign pathogens or host-derived molecules, TLRs signal via overlapping or distinct signaling cascades and eventually induce numerous genes involved in a variety of cellular responses. A growing body of evidence suggests that TLR signaling also plays an important role in cardiac ischemia/reperfusion injury. We review our current understanding of the TLR signaling pathways and their roles in the pathophysiology of cardiac ischemia/reperfusion injury, as well as discuss several mechanisms for TLR activation and regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458266     DOI: 10.1097/SHK.0b013e3181e686f5

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  8 in total

Review 1.  The role of Toll-like receptors in retinal ischemic diseases.

Authors:  Wen-Qin Xu; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

2.  Hyaluronan regulation of vascular integrity.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 3.  Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor.

Authors:  Gemma Vilahur; Lina Badimon
Journal:  Front Physiol       Date:  2014-12-18       Impact factor: 4.566

4.  Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.

Authors:  Nicholas Chun; Ala S Haddadin; Junying Liu; Yunfang Hou; Karen A Wong; Daniel Lee; Julie I Rushbrook; Karan Gulaya; Roberta Hines; Tamika Hollis; Beatriz Nistal Nuno; Abeel A Mangi; Sabet Hashim; Marcela Pekna; Amy Catalfamo; Hsiao-Ying Chin; Foramben Patel; Sravani Rayala; Ketan Shevde; Peter S Heeger; Ming Zhang
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

5.  Gene expression profiling analysis to investigate the role of remote ischemic postconditioning in ischemia-reperfusion injury in rats.

Authors:  Zanxin Wang; Junmin Wen; Chuzhi Zhou; Zhiwei Wang; Minxin Wei
Journal:  BMC Genomics       Date:  2019-05-09       Impact factor: 3.969

6.  Rapid Lipid Modification of Endothelial Cell Membranes in Cardiac Ischemia/Reperfusion Injury: a Novel Therapeutic Strategy to Reduce Infarct Size.

Authors:  Claudio Maldonado; Mai-Dung Nguyen; Phillip Bauer; Shunichi Nakamura; Syed J Khundmiri; Gustavo Perez-Abadia; Heather L Stowers; Wen-Jian Wu; Xian-Liang Tang
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-20       Impact factor: 3.727

7.  Resveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-κB signaling pathway.

Authors:  Cui Zhang; Guosheng Lin; Weiguo Wan; Xuyon Li; Bin Zeng; Bo Yang; Congxin Huang
Journal:  Int J Mol Med       Date:  2012-01-11       Impact factor: 4.101

Review 8.  Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury.

Authors:  Qing Liu; Jiqiang Li; Jing Wang; Jianping Li; Joseph S Janicki; Daping Fan
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-31       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.